Monthly Archives: October 2016

 

Alma Crowdfunds for Crohn’s Therapy

Alma is preparing a therapy for testing in patients with Crohn’s Disease.The company plans to conduct the early stage clinical testing. Then, Alma will license the therapy to a larger company and collect royalties from drug sales. </p> Crowdfunding has emerged as a solution and a major opportunity to find...
Read more

BioLineRx Phase 2a for Pancreatic Cancer

BioLineRx Ltd. (NASDAQ/TASE:BLRX) today announced the initiation of a Phase 2a trial investigating BL-8040 in combination with KEYTRUDA┬« (pembrolizumab), MSD’s anti-PD-1 therapy, in patients with metastatic pancreatic cancer. The Phase 2a study, named the COMBAT study, is an open-label, multicenter, single-arm trial designed to evaluate the safety and efficacy of...
Read more